Article
Impact of national guidance for drug prescribing for dentistry
Search Medline for
Authors
Published: | July 10, 2012 |
---|
Outline
Text
Background: Guidance for prescribing in dentistry was first published in 2008 in response to concerns about inappropriate prescribing of antibiotics. Publication coincided and included recommendations in NICE guidance for prophylactic prescribing of 3g amoxillin for infective endocarditis.
Objectives: To monitor target drugs, to assess the impact of guidance and to inform the need for and design of implementation strategies.
Methods: Routine data on prescribing by all individual dentists in Scotland were monitored, analysed and trends identified.
Results: The trend in routine data represent a reduction of 70% in the prescribing of 3g amoxicillin within three months following the publication of national guidance. There has been no further reduction and approximately 400 prescriptions are fulfilled each month. Total antibiotic prescribing by dentists, which accounts for around 10% of all primary care antibiotic prescribing, is steadily increasing.
Discussion: While the prescribing of prophylactic antibiotics has fallen significantly, the publication of guidance alone has not reduced total antibiotic prescribing by dentists. With increasing use of warfarin and statins, concerns about possible harmful co-prescribing are heightened. This work has informed the development of a multifaceted implementation strategy, including a prescribing smartphone app that gives ready access to interaction information.
Implications for guideline developers/users: Monitoring of routine data can be an invaluable tool to support guidance implementation.